Patent ID: 7268161
Filing Date: 2007-09-11
Classification: A61K,A61P,Y10S

Abstract:
1. A method to facilitate weight loss for a patient not suffering from depression, said method comprising administration of a selective Serotonin reuptake inhibitor (SSRI), Phentermine, 5-Hydroxytryptophan and Tyrosine, wherein said SSRI, said Phentermine, said 5-Hydroxytryptophan, and said Tyrosine are administered in an effective therapeutic range to effectuate weight loss, and wherein said SSRI is selected from the group consisting of Citalopram, S-Citalopram, Fluoxetine Hydrochloride, Sertraline, Fluvozxamine Maleate, and Trazodone Hydrochloride.